MTOR and neoplasm: SCFAs activate mTOR signaling in immune cells to provide anti-microbial and anti-tumor immunity, and they also promote the production of IgA mucosal immunity and systemic IgG production, while suppressing IgE-associated allergic responses [127, 128], which together also contribute to immunological homeostasis.